Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 5/20 | 0.44 |
| ▸ | GSK3B | P49841 | 5/20 | 0.43 |
| ▸ | TRPV4 | Q9HBA0 | 3/20 | 0.36 |
| ▸ | ITGA1 | P56199 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SLC40A1 | Q9NP59 | 2/20 | 0.33 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14546009 | 0.90 | CDK2 (0.46) | CDK2GSK3BALDH1A1CYP1A2POLB | |
| SCHEMBL13121256 | 0.90 | CDK2 (0.58) | CDK2GSK3BTRPV4 | |
| SCHEMBL13289547 | 0.89 | CDK2 (0.46) | CDK2GSK3BSLC40A1CCR1 | |
| SCHEMBL12954142 | 0.88 | CDK2 (0.43) | CDK2GSK3BPOLBMAPTCCR1 | |
| SCHEMBL13289569 | 0.88 | CDK2 (0.51) | CDK2GSK3B | |
| SCHEMBL13289063 | 0.88 | GSK3B (0.45) | CDK2GSK3BALDH1A1POLBCCR1 | |
| SCHEMBL13289301 | 0.88 | CDK2 (0.46) | CDK2GSK3BALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL13288981 | 0.88 | CDK2 (0.46) | CDK2GSK3BALDH1A1MAPTCCR1 | |
| SCHEMBL13289071 | 0.87 | CDK2 (0.43) | CDK2GSK3BALDH1A1 | |
| SCHEMBL13289126 | 0.86 | GSK3B (0.47) | CDK2GSK3BALDH1A1CYP1A2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194058-A1 | Pyrazolopyrimidines suitable for the treatment of cancer diseases | SCHERING CORPORATION (US) | 2010-06-09 | — | — | EP | disclosed |